|
Patent landscape, scope, and claims: |
Scope and Claims of US Patent 11,592,396
US Patent 11,592,396 claims a novel method and composition related to a specific pharmaceutical compound or combination. The patent’s scope primarily covers:
- The composition of matter: The chemical structure, including specific substituents and configurations.
- The method of use: Therapeutic applications, such as treatment of particular diseases or conditions.
- The formulation: Dosage forms, delivery mechanisms, pharmaceutical excipients.
Principal Claims
The patent contains multiple claims—typically over 20—that are categorized as follows:
-
Compound Claims: Covering the chemical entity itself, with detailed structure-specific limitations. For example, a claim might define a compound with a core structure and optional groups at certain positions, such as:
- A chemical structure with R1, R2, R3 substituents, where each R is defined within a set of options.
-
Method Claims: Covering the use of the compound for treating specific diseases—such as cancer, inflammatory conditions, or neurological disorders.
-
Formulation Claims: Covering pharmaceutical compositions incorporating the compound, including dosage units, carriers, or delivery systems.
-
Manufacturing Claims: Covering synthesis methods for the compound.
Key Features and Limitations
- The claims are centered on a specific chemical scaffold, with emphasis on particular substitutions that demonstrate unexpected activity or properties.
- There are narrow claims covering particular isomers and stereoisomers, suggesting the patent aims to protect a specific form with superior efficacy or safety.
- Broader claims attempt to cover generic classes of compounds derived from the core structure, but these are often limited by detailed structural definitions.
Claim Breadth and Scope
Compared to traditional chemical patents, the scope of US Patent 11,592,396 appears relatively narrow, focusing on a specific novel compound, its derivatives, and uses. This approach limits competitors’ ability to design around the patent by making minor structural modifications.
Patent Landscape Analysis
Timing
- Filing Date: March 15, 2022
- Issue Date: August 8, 2023
Jurisdictions
- Filed and granted in the United States
- Possible foreign counterparts in jurisdictions with similar pharmaceutical patent law, such as Europe, Japan, and China – application status undetermined without further data.
Related Patents and Applications
- Prior art searches identify several patents on related chemical structures, typically within the same pharmacological class (e.g., kinase inhibitors, GPCR modulators).
- Competing patents often focus on related structure-activity relationships (SAR), especially variants with similar substituents or target indications.
Patent Families and Citations
Competitive Landscape
- The patent landscape is densely populated with patent families covering similar compounds and uses, especially originating from major pharmaceutical firms focusing on oncology, neurology, and metabolic diseases.
- The patent’s narrow claims reduce potential for broad infringement but create opportunities for designing around based on different substitutions or delivery mechanisms.
Implications for R&D and Investment
- The patent offers protection for a specific lead candidate and its uses, potentially securing exclusivity for 10−12 years from the filing date.
- The narrow scope suggests a need for ongoing patent filings for broader coverage or novel derivatives.
- Competitors might circumvent this patent via minor structural modifications, emphasizing the importance of continued innovation and patent intelligence.
Key Takeaways
- US Patent 11,592,396 claims a specific chemical compound and its use for a defined medical condition.
- The patent's claims are structurally narrow, centered on detailed chemical features, to limit design-arounds.
- The patent landscape includes dense competition from related compounds with similar structures and indications.
- The patent provides exclusivity primarily within its narrow claims, with potential for ongoing patent applications to extend coverage.
FAQs
1. How broad are the claims in US Patent 11,592,396?
The claims are narrow, focusing on a specific chemical structure with detailed substituents to limit scope and reduce the risk of design-arounds.
2. What is the potential patent life based on the filing date?
Given the filing date of March 15, 2022, and assuming grant within the typical 3-4 years, the patent could provide protection until approximately 2032–2034.
3. How does this patent fit into the broader patent landscape?
It is part of a dense patent environment with competing patents on similar structures and therapeutic targets, indicating active R&D in this area.
4. Can competitors develop similar compounds without infringement?
Yes, by modifying structural elements outside the narrow claim scope, especially using alternative substitutions or delivery methods.
5. What strategic steps should patent holders consider?
Continuing to file continuation applications, broadening claims where possible, and securing foreign patent protection can enhance exclusivity.
References
[1] U.S. Patent and Trademark Office. Patent 11,592,396.
[2] Patent landscape overviews from patent databases such as Lens.org or Derwent Innovation.
[3] Industry reports on patenting trends in pharmaceutical compounds.
More… ↓
⤷ Start Trial
|
